Toll Group has announced it is investing $100 million AUD in healthcare services across Asia Pacific.
This investment will grow supply chain capabilities and assets, and provide scalability for customers across Southeast Asia and beyond, the company said in a statement.
In Australia, it will include the construction of several specialist healthcare facilities. These include a centre in Melbourne for CSL Seqirus, and a new facility in Richlands, Queensland for vaccine distribution. Additionally, Toll is set to open a facility in Hazelmere, Western Australia by mid-2025.
‘We anticipate this investment will generate hundreds of new jobs in Australia and Asia,’ said Toll’s Chief Enterprise Services Officer, Anna Green. ‘In Australia, around 130 healthcare jobs have been added to Toll’s existing 6,000-plus strong workforce, which is expected to grow as further investments in property and technologies are made.”
Growing demand for healthcare services is fuelling Toll’s expansion in Southeast Asia. Toll is upgrading its flagship facility, Toll City, located in Tuas, Singapore. This almost 10,000-square metre facility currently supports more than 100 customers with their specialised warehouse and transport needs. The expansion at Toll City, along with the construction of a new site in Port Klang, Malaysia, will add another 65,000 square metres of warehouse space.
Toll Group’s Head of Healthcare Vertical, Sugantha Natarajan, said that the investment creates a seamless network for businesses moving products across the region.
“Companies partnering with Toll can leverage our extensive multi-modal network, cold chain storage, delivery services, and solutions for hospitals, healthcare providers, and patients,” she said. “Our existing healthcare facilities in China and India further strengthen this strategic network for faster, more reliable, and efficient transportation and storage solutions.”
In other news, Goodyear and Krone Trailer have signed an agreement.